Singer, Emily
July 2008
Technology Review;Jul2008, Vol. 111 Issue 4, p18
The article presents various genetic tests which are intended to promote the falling cost of genomic technologies as well as cites the companies producing such equipment. It includes Genographic Project, which features their fragment analysis that can help consumers know their ancestors whom they share genetic features. Another is DNA Direct, which introduces its subcontractors which can document genetic components, with test results informing preventive measures to counter genetic diseases. It also includes Knome Inc., which offers its sequencing technology that gives customers a personalized report on their ancestry and sequence myriad genetic variations that cannot be identified.


Related Articles

  • Weighted selective collapsing strategy for detecting rare and common variants in genetic association study.  // BMC Genetics;2012, Vol. 13 Issue 1, p7 

    The article offers information on a study conducted on weighted selective collapsing strategy for candidate gene studies and genome-wide association scans. It states that with the development of next-generation sequencing technologies, rare variants can be genotyped. It mentions that common and...

  • Is genetic screening for the Lynch syndrome effective? Misak, Aleksandra // CMAJ: Canadian Medical Association Journal;6/7/2005, Vol. 172 Issue 12, p1557 

    Discusses research being done on the effectiveness of genetic screening for the Lynch syndrome. Reference to a study by H. Hampel et al, published in the 2005 issue of the "New England Journal of Medicine"; Background of the research; Results; Practice implications.

  • Asymptomatic proteinuria, renal cysts and dorsal pancreas agenesis. Lim, Cynthia C.; Lai, Angeline H.M.; Choo, Jason C.J. // Clinical Kidney Journal;Aug2014, Vol. 7 Issue 4, p411 

    The article presents a case study of 28-year-old woman with no significant past medical history and no family history of diabetes mellitus or kidney disease. Physical examination found mild cortical scarring in the upper pole of the right kidney but no hydronephrosis. Clinical findings suggested...

  • ANALYZING ILLUMINA HUMAN 1M SNP DATA FOR CNVS USING RAW BEAD-LEVEL DATA. Shah, Naisha; Conroy, Judith; Regan, Regina; Ennis, Sean; Shields, Denis C. // Ulster Medical Journal;2009, Vol. 78 Issue 1, p67 

    With the advent of high-throughput genotyping chips, whole genome association studies are undertaken to determine potential candidate loci by linking common SNPs and copy number variations to human disorders like autism. Illumina's Human 1M SNP beadchip is one of the high-throughput genotyping...

  • Editorial: The shifting nature of genome scans.  // New Scientist;8/1/2009, Vol. 203 Issue 2719, p3 

    The authors comment on the nature of genome scans or genetic screening. They relate how a genome scan can motivate a person to take the steps necessary to prevent a disease. Information is presented on the importance of environmental factors like diet and exercise in determining who succumbs to...

  • Genetic Test Indications and Interpretations in Patients With Hereditary Angioedema. Weller, Catherine R.; van Dellen, Richard G. // Mayo Clinic Proceedings;Jul2006, Vol. 81 Issue 7, p958 

    Patients with hereditary angioedema (HAE) present with recurrent, circumscribed, and self-limiting episodes of tissue or mucous membrane swelling caused by C1-inhibitor (C1-INH) deficiency. The estimated frequency of HAE is 1:50,000 persons. Distinguishing HAE from acquired angioedema (AAE)...

  • Clinical utility gene card for: Dyskeratosis congenita. Dokal, Inderjeet; Vulliamy, Tom; Mason, Philip; Bessler, Monica // European Journal of Human Genetics;Nov2011, Vol. 19 Issue 11, p1 

    The article offers information on genetic testing for dyskeratosis congenital (DC). It presents a series of questions that should be answered prior to the administration of genetic testing which include the effect of disease management to test result, effect of the test result to lifestyle and...

  • Patient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods. Hollands, Gareth J.; Armstrong, David; Macfarlane, Angela; Crook, Martin A.; Marteau, Theresa M. // BMC Medical Genetics;2012, Vol. 13 Issue 1, p87 

    Background: Continuing developments in genetic testing technology together with research revealing gene-disease associations have brought closer the potential for genetic screening of populations. A major concern, as with any screening programme, is the response of the patient to the findings of...

  • Genetic Screening in Europe. Javaher, P.; Nyoungui, E.; Kääriäinen, H.; Kristoffersson, U.; Nippert, I.; Sequeiros, J.; Schmidtke, J. // Public Health Genomics;2010, Vol. 13 Issue 7/8, p524 

    Genetic screening has been defined as any kind of test performed systematically for the early detection or exclusion of a genetic disease, genetic predisposition or resistance to a disease, or to determine whether a person carries a gene variant that may produce disease in his or her offspring....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics